A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

Julie N. Graff, Tomasz M. Beer, Joshi J. Alumkal, Rachel E. Slottke, William L. Redmond, George V. Thomas, Reid F. Thompson, Mary A. Wood, Yoshinobu Koguchi, Yiyi Chen, Emile Latour, Raymond C. Bergan, Charles G. Drake, Amy E. Moran

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone'. Together they form a unique fingerprint.

Medicine & Life Sciences